New role will boost strategy for scalable solutions
Peter Crossley

Company news

New role will boost strategy for scalable solutions

15 Feb, 2024

Published over 2 years ago. See the latest and most current information on Company news.

TTP Company Cellular Origins has appointed Peter Crossley as Chief Operating Officer (COO), to bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture. Bringing 27 years’ experience in novel technology and product development to this key role, he will be responsible for driving team growth and overseeing people development at the company.

Having worked as a Consultant at TTP for the past 17 years, he was most recently interim CTO at Depixus. With a BEng in Aerospace Engineering from the University of Bristol, Peter began his career in gas turbine development at Rolls-Royce, before moving to R&D and technical management in consumer products at Dyson and Fisher & Paykel.

“Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”

Dr Edwin Stone, CEO at Cellular Origins, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills and ability to turn ground-breaking innovation into commercial reality, will accelerate our mission to develop scalable automation solutions for cell therapies.”

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow